Cargando…

Comparison of the diagnostic performance of H/M ratio between early and delayed phases for Lewy body disease

OBJECTIVES: The aim of the study was to compare the diagnostic performance of early-phase (123)I-metaiodobenzylguanidine (MIBG) scintigraphy with that of delayed-phase imaging in Lewy body disease (LBD). METHODS: A retrospective cohort study of (123)I-MIBG scintigraphy was carried out in 192 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maruyama, Yasuki, Yamada, Takayuki, Murakami, Kenji, Kumano, Reiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482458/ https://www.ncbi.nlm.nih.gov/pubmed/25714666 http://dx.doi.org/10.1097/MNM.0000000000000271

Ejemplares similares

Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions
por: Yamada, Masahito, et al.
Publicado: (2020)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial
por: Mori, Etsuro, et al.
Publicado: (2015)

Primary ovarian leiomyoma with predominant cystic change
por: Asada, Tatsunori, et al.
Publicado: (2019)

Lewy body disease or diseases with Lewy bodies?
por: Menšíková, Kateřina, et al.
Publicado: (2022)

Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses
por: Lamotte, Guillaume, et al.
Publicado: (2015)

Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
por: Matsubara, Tomoyasu, et al.
Publicado: (2022)

Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Jellinger, Kurt A.
Publicado: (2022)

Zonisamide improves axial symptoms in dementia with Lewy bodies with parkinsonism: Post hoc analysis of clinical trials()
por: Tsuboi, Yoshio, et al.
Publicado: (2021)

Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies
por: Thomas, Alan J., et al.
Publicado: (2019)

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease
por: Bousiges, Olivier, et al.
Publicado: (2022)

Long reaction times are associated with delayed brain activity in lewy body dementia
por: Firbank, Michael J., et al.
Publicado: (2017)

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
por: Ikeda, Manabu, et al.
Publicado: (2015)

Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
por: Menšíková, Kateřina, et al.
Publicado: (2022)

Diagnostic Accuracy of (123)I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study
por: Yoshita, Mitsuhiro, et al.
Publicado: (2015)

Recurrent hyperparathyroidism due to parathyroid and pulmonary tumors showing features of parathyroid adenoma
por: Miyauchi, Ryosuke, et al.
Publicado: (2020)

Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition
por: Ishii, Kazunari, et al.
Publicado: (2014)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Lewy body constipation
por: Sakakibara, Ryuji, et al.
Publicado: (2019)

A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment
por: Capouch, Samuel D., et al.
Publicado: (2018)

Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
por: Caminiti, Silvia Paola, et al.
Publicado: (2019)

Implication of EEG theta/alpha and theta/beta ratio in Alzheimer’s and Lewy body disease
por: Baik, Kyoungwon, et al.
Publicado: (2022)

Can early phase cardiac [(123)I]mIBG images be used to diagnose Lewy body disease?
por: Roberts, Gemma, et al.
Publicado: (2022)

Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
por: Galvin, James E.
Publicado: (2015)

Anosognosia in dementia with Lewy bodies: a systematic review
por: CALIL, Victor, et al.
Publicado: (2021)

Case report: Delusional infestation in dementia with Lewy bodies
por: Taomoto, Daiki, et al.
Publicado: (2022)

Cholinergic muscarinic M(1)/M(4) receptor networks in dementia with Lewy bodies
por: Colloby, Sean J, et al.
Publicado: (2020)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review
por: Jreige, Mario, et al.
Publicado: (2023)

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
por: Hatton, Christopher, et al.
Publicado: (2020)

Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial
por: Mori, Etsuro, et al.
Publicado: (2012)

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
por: Berge, Guro, et al.
Publicado: (2014)

Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
por: Su, Bo, et al.
Publicado: (2009)

Dr. Lewis H. Hazeltine
Publicado: (1913)

Speech and language characteristics differentiate Alzheimer's disease and dementia with Lewy bodies
por: Yamada, Yasunori, et al.
Publicado: (2022)

Challenging delayed bleeding after an Ivor Lewis oesophagectomy
por: Liddle, Sean, et al.
Publicado: (2020)

Characteristics of Drawing Process Differentiate Alzheimer’s Disease and Dementia with Lewy Bodies
por: Yamada, Yasunori, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_khotegctda5no2p37fauo39oen